Antioxidant peptides, hatched eggshell membrane hydrolysate containing antioxidant peptides and application thereof
Through the hydrolysis and separation technology of incubating eggshell membranes, peptide sequences with high antioxidant activity were prepared, which solved the problems of resource waste and environmental pollution, and provided natural treatment plans for diseases such as osteoarthritis, achieving oxidative response effective protection.
Patent Information
- Application Number
- CN202111667462.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-31
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2041-12-31
AI Technical Summary
The existing technology fails to effectively utilize the incubated eggshell membrane resources, resulting in waste of biological resources and environmental pollution, and at the same time, there is a lack of natural antioxidant peptide solutions for diseases such as osteoarthritis.
Incubate the eggshell membrane by hydrolytic enzyme treatment, and combine ultrafiltration, glucan gel chromatography and reverse phase high performance liquid chromatography for separation and purification. Antioxidant peptide sequences, such as LWNPR, MDGWPR, DGGLPPM, were identified and screened for the preparation of anti-oxidant peptide sequences, such as LWNPR, MDGWPR, and DGGLPPM, for the preparation of anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-ant Oxidation of peptides and incubating eggshell membrane hydrolysate.
It realizes efficient preparation of antioxidant peptides, has high antioxidant activity, can protect chondrocytes from oxidative stress damage, regulate Keap1-Nrf2 signaling pathway, significantly improves cell survival and proliferation index, and provides a green and environmentally friendly source of antioxidants. .
Smart Images

Figure CN115197295B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biological small molecule active peptides, in particular to antioxidant peptides, hatched eggshell membrane hydrolysates containing the antioxidant peptides and applications thereof. Background Art
[0002] Free radicals have high activity and strong oxidative reaction ability. They can attack macromolecules in the body through oxidative reactions, thereby causing damage to cell structure and function, leading to tissue damage and organ damage, and the imbalance of continuous oxidative stress and body defense, leading to the occurrence of diseases such as osteoarthritis, heart disease, diabetes, and cancer. In addition, food deterioration is mainly caused by lipid oxidation and lipid secondary oxidation. Many synthetic antioxidants, such as butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT), although having high antioxidant activity, are limited in their use because they may induce side effects such as DNA damage and body toxicity. Antioxidants extracted from natural resources, such as antioxidant peptides, are used in food and pharmaceutical health products with higher safety.
[0003] The Keap1-Nrf2 signaling pathway is the most important endogenous antioxidant signaling pathway in cells. When cells are exposed to oxidative stress, Nrf2 is released from the Keap1-Nrf2 complex and enters the nucleus to promote the expression of antioxidant genes. Antioxidants derived from natural ingredients can alleviate H2O2-induced oxidative stress, inflammation, and cartilage degradation by activating the Keap1-Nrf2 pathway. Regulating the Keap1-Nrf2 signaling pathway is expected to become a feasible treatment for osteoarthritis.
[0004] Eggshells are an important component of hatchery waste, consisting of calcium carbonate shells, membranes, proteins and active peptides derived from embryos, and other contaminants (including microorganisms) wrapped in the eggshell. It is reported that hatching eggshell membranes contain a large amount of bioactive proteins, peptides, enzymes, and a variety of microbial protein factors. Currently, the utilization rate of hatching eggshells is low, most of which are discarded, and only a small part is added to feed and fertilizer, which has caused a great waste of biological resources and environmental pollution.
[0005] At present, there are reports on the preparation of peptides from fresh eggshell membranes, such as Chinese patent CN 108323764 B, which reports that fresh eggshell membranes can be used to prepare protein hydrolysates with bone and joint protection effects, but does not provide the structure and sequence of specific active peptides. So far, there are no reports at home and abroad on the application of hatching eggshell membranes in the preparation of bioactive peptides. The development of hatching eggshell membrane antioxidant peptides is conducive to the high-value utilization of hatchery eggshell membrane waste resources, and also provides a new source for the preparation of antioxidant peptides. Summary of the invention
[0006] In view of the deficiencies of the prior art, the present invention provides antioxidant peptides, hatching eggshell membrane hydrolysates containing antioxidant peptides and applications thereof. The present invention hydrolyzes hatching eggshell membranes with appropriate proteolytic enzymes to obtain hatching eggshell membrane hydrolysates, separates and purifies the hydrolysates by ultrafiltration, dextran gel chromatography and reversed-phase high performance liquid chromatography, measures the chemical and cellular antioxidant activity of each component, then performs peptideomics identification by LC-MS / MS, combines bioinformatics means to screen active peptide sequences, solid phase synthesis, and verifies its activity, thereby completing the present invention.
[0007] In order to achieve the above object, the present invention adopts the following technical solutions:
[0008] An antioxidant peptide, characterized in that its amino acid sequence is any one of the following sequences:
[0009] LWNPR (Leu-Trp-Asn-Pro-Arg);
[0010] MDGWPR(Met-Asp-Gly-Trp-Pro-Arg);
[0011] DGGLPPM (Asp-Gly-Gly-Leu-Pro-Pro-Met).
[0012] A hatched eggshell membrane hydrolyzate comprising one or more of the following antioxidant peptides;
[0013] An antioxidant peptide with an amino acid sequence of LWNPR (Leu-Trp-Asn-Pro-Arg);
[0014] An antioxidant peptide with an amino acid sequence of MDGWPR (Met-Asp-Gly-Trp-Pro-Arg);
[0015] An antioxidant peptide with the amino acid sequence of DGGLPPM (Asp-Gly-Gly-Leu-Pro-Pro-Met).
[0016] A food containing the above antioxidant peptide or hatched eggshell membrane hydrolyzate.
[0017] An antioxidant drug containing the above antioxidant peptide or hatched eggshell membrane hydrolyzate.
[0018] A health product containing the above antioxidant peptide or hatched eggshell membrane hydrolyzate.
[0019] The dosage of hatching eggshell membrane hydrolyzate in food, antioxidant medicine or health care product is 4-40 mg / kg.
[0020] An antioxidant beauty product contains the antioxidant peptide or hatched eggshell membrane hydrolyzate.
[0021] Preferably, the addition amount of the hatching eggshell membrane hydrolyzate is 0.1-10wt%.
[0022] Preferably, the beauty products include facial masks, facial creams and lotions.
[0023] Use of the above antioxidant peptide or hatched eggshell membrane hydrolyzate in the manufacture of antioxidants.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] (1) The present invention uses hatching eggshell membrane to prepare antioxidant peptides for the first time, which rationally utilizes hatchery waste resources and avoids their environmental pollution. It has the advantages of novel raw materials, green environmental protection, and sustainable development;
[0026] (2) The antioxidant peptides provided by the present invention have a molecular weight of less than 1000 Da and are easily absorbed.
[0027] (3) The antioxidant peptides of the present invention have high antioxidant activity, wherein the ORAC values of the antioxidant peptides MDGWPR, LWNPR, and DGGLPPM are 4.59, 4.46, and 2.46 times that of GSH, respectively. The antioxidant peptides of the present invention and the hydrolyzates containing the antioxidant peptides can protect inflammatory cells (RAW264.7) and chondrocyte cell lines (SW1353) from damage by oxidative stress, and can promote the proliferation of chondrocyte cell lines (SW1353).
[0028] (4) The method of the present invention involves bioinformatics screening, in vitro and in vivo antioxidant activity verification, and studies and verifies the antioxidant activity of antioxidant peptides and hatched eggshell membrane hydrolysates containing the antioxidant peptides from multiple angles.
[0029] (5) The novel antioxidant peptide of the present invention, in addition to its in vitro antioxidant activity, can effectively regulate the Keap1-Nrf2 signaling pathway of the body's antioxidant pathway and has the potential to target and bind to Keap1. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 ORAC values of ultrafiltration fractions of different molecular weights of hatched eggshell membrane hydrolysate in Example 2 of the present invention (different letters indicate significant differences P<0.05);
[0031] Figure 2 These are the results of the antioxidant capacity determination of the preferred hatching eggshell membrane antioxidant peptides (different letters for the same index indicate significant differences P<0.05);
[0032] Figure 3 is the mass spectrum of the hatched eggshell membrane antioxidant peptide LWNPR;
[0033] Figure 4 is the mass spectrum of the hatched eggshell membrane antioxidant peptide MDGWPR;
[0034] Figure 5 is the mass spectrum of the hatched eggshell membrane antioxidant peptide DGGLPPM;
[0035] Figure 6 The effect of the antioxidant peptide LWNPR on the expression of proteins related to the Keap1-Nrf2 signaling pathway in cells;
[0036] Figure 7 This is the result of molecular docking between the antioxidant peptide LWNPR and the key cellular antioxidant protein Keap1. DETAILED DESCRIPTION
[0037] The present invention is further described below in conjunction with examples, but it should be noted that the examples do not limit the scope of protection claimed in the present invention.
[0038] The antioxidant peptides and hatching eggshell membrane hydrolysates containing the antioxidant peptides of the present invention have the characteristics of novel raw materials, low cost, green environmental protection, and high antioxidant peptide activity. Finally, three polypeptides with high antioxidant activity were separated and identified from the hatching eggshell membrane hydrolysates. The amino acid sequences of the antioxidant peptides are: LWNPR, MDGWPR, DGGLPPM, respectively. After searching and comparing with the existing active peptide database BIOPEP, it was found that none of them had been reported, and they were new antioxidant peptides. After chemical antioxidant activity verification, the peptides involved in the present invention showed high free radical scavenging activity, which can promote the proliferation of chondrocytes (SW1353), and can significantly improve the cell survival rate of chondrocytes and immune cells induced by H2O2.
[0039] The specific peptide sequences and activity assay results are as follows:
[0040] (1) The antioxidant peptides MDGWPR, LWNPR, and DGGLPPM showed high ORAC values, and their results were better than those of the positive control GSH. At the same time, MDGWPR and LWNPR showed high ABTS free radical scavenging activity, and their results were significantly higher than those of GSH. The antioxidant peptides LWNPR, DGGLPPM, and MDGWPR showed high DPPH free radical scavenging activity, and the results of MDGWPR were better than those of GSH.
[0041] (2) Preferably, the hatched eggshell membrane antioxidant peptide LWNPR can increase the expression of Nrf2 and HO-1 in RAW264.7 cells induced by H2O2, thereby activating the Keap1-Nrf2 signaling pathway and exerting antioxidant activity.
[0042] (3) Molecular docking results showed that the hatched eggshell membrane antioxidant peptides MDGWPR, LWNPR, and DGGLPPM could occupy the Nrf2 binding site in the Keap1 Kelch domain, inhibit the ubiquitination and degradation of Nrf2, and thus activate the Keap1-Nrf2 signaling pathway.
[0043] (4) The hatched eggshell membrane hydrolyzate containing the antioxidant peptide sequence of the present invention can significantly improve the cell survival rate of the H2O2-induced SW1353 cell oxidative damage model. When the concentration is 0.75 mg / mL, the survival rate of SW1353 cells can be increased by 67.58% compared with the model group.
[0044] (5) Pretreatment with 0.75 mg / mL of the hatched eggshell membrane hydrolyzate containing the antioxidant peptide sequence of the present invention can promote the proliferation of SW1353 cells. Compared with the blank group, the cell proliferation index reached 3.
[0045] (6) The hatched eggshell membrane hydrolyzate containing the antioxidant peptide sequence of the present invention can significantly improve the cell survival rate of the RAW264.7 cell oxidative damage model induced by H2O2. When the concentration is 0.75 mg / mL, the survival rate of RAW264.7 cells can be increased by 55.81% compared with the H2O2 model group.
[0046] It should be noted that, as a typical example, the three antioxidant peptides involved in the present invention can be obtained from hatching eggshell membrane hydrolysate by separation and purification, and can also be prepared by other methods known in the art, such as chemical synthesis and genetic engineering.
[0047] The antioxidant peptide of the present invention may be used as an antioxidant after being separated from a hatched eggshell membrane hydrolyzate containing the peptide, or may be used as an antioxidant in a form contained in a hatched eggshell membrane hydrolyzate.
[0048] The antioxidant peptides involved in the present invention are measured by the method described in (Habinshuti I, Mu TH, Zhang M. Ultrasound microwave-assisted enzymatic production and characterization of antioxidant peptides from sweet potato protein [J]. Ultrason Sonochem, 2020, 69: 105262.) to determine the ORAC value.
[0049] The method for determining the scavenging rate of ABTS and DPPH free radicals was determined by referring to the methods described in (Liying Wang, Mengting Ma, Zhipeng Yu, Shuang-kui Du. Preparation and identification of antioxidant peptides from cottonseed proteins [J]. Food Chemistry, 2021, 352: 129399.) and (Qiaozhi Zhang, Xiaohong Tong, Yang Li, Huan Wang, Zhongjiang Wang, Baokun Qi, Xiaonan Sui, Lianzhou Jiang. Purification and characterization of antioxidant peptides from Alcalase-hydrolyzed soybean (Glycine max L.) hydrolysate and their cytoprotective effects in human intestinal Caco-2 cells [J]. Agricultural and Food Chemistry. 2019: 1-36.).
[0050] Hereinafter, the present invention will be described in more detail by way of examples.
[0051] Example 1
[0052] <Preparation of hatched eggshell membrane hydrolyzate>
[0053] a. Obtaining hatching eggshell membrane:
[0054] It comes from the hatching eggshell waste from the breeding farm. The hatching eggshell membrane is torn off, washed with pure water, and dried for later use.
[0055] b. Preparation of hatching eggshell membrane hydrolysate:
[0056] The hatching eggshell membrane is mixed with pure water at a ratio of 1:10 to 1:60 (w / v), the pH value of the solution is adjusted to 8.0 to 10.0, and metalloproteinase and serine protease are added at an enzyme amount of 1% to 5% (w / w), and the reaction is carried out at 50 to 60°C for 8 to 10 hours. After the reaction is completed, the beaker containing the hydrolyzate is placed in 80 to 100°C hot water for 10 to 30 minutes to inactivate the protease, and then placed at room temperature or cold water. After cooling to room temperature, the pH of the hydrolyzate is adjusted back to between 7.0 and 7.6 using a hydrochloric acid solution. The hydrolyzate is centrifuged at 8000 to 12000 r / min for 10 to 30 minutes, and the supernatant is stored at -20°C for standby use. The supernatant is the hatching eggshell membrane hydrolyzate.
[0057] Example 2
[0058] <Ultrafiltration Separation>
[0059] 1) Ultrafiltration of crude polypeptides: The prepared hatched eggshell membrane hydrolysate is placed at 4° C. to thaw, and then the supernatant is filtered through a 30 kDa filter membrane to retain polypeptides with a molecular weight greater than 30 kDa in the supernatant to obtain a first ultrafiltrate; then a second ultrafiltration is performed using an ultrafiltration membrane with a molecular weight cutoff of 10 kDa to obtain a second ultrafiltrate; the second ultrafiltrate is further ultrafiltered using an ultrafiltration membrane with a molecular weight cutoff of 3 kDa to obtain a third ultrafiltrate, and finally four ultrafiltration fractions with molecular weights of >30 kDa, 30-10 kDa, 10-3 kDa, and <3 kDa are obtained, and the ultrafiltration fractions with different molecular weights are freeze-dried for subsequent activity determination.
[0060] 2) respectively measuring the oxygen radical absorption capacity (ORAC) of the different molecular weight components obtained in 1), and selecting the component with the largest ORAC value for amino acid sequence identification. The ORAC values of the ultrafiltration components of different molecular weights of the hatched eggshell membrane hydrolysate are as follows: Figure 1 As shown, the ultrafiltration fraction <3 kDa showed the highest ORAC value, which was significantly higher than the ORAC values of other ultrafiltration fractions.
[0061] Example 3
[0062] <Mass spectrometry identification of antioxidant peptides from hatching eggshell membrane>
[0063] The amino acid sequence of the ultrafiltration fraction <3 kDa was determined by liquid chromatography-tandem mass spectrometry (LC-MS / MS). LC-MS / MS was performed using an Eksignent nano-LC instrument (Eksigent Technologies, Dublin, CA, USA) coupled to a Thermo LTQ linear ion trap mass spectrometer (Thermo Fisher, San Jose, CA, USA) and an LC Packins PepMap300 C18 column (75 μm × 150 mm; pore size The eluent A contained 2% ACN and 0.1% formic acid, and the eluent B contained 80% ACN and 0.1% formic acid. The eluent A contained 2% ACN and 0.1% formic acid. The eluent B contained 80% ACN and 0.1% formic acid. The eluent A contained 2% ACN and 0.1% formic acid. The eluent B contained 80% ACN and 0.1% formic acid. The eluent A contained 2% ACN and 0.1% formic acid. The eluent B contained 80% ACN and 0.1% formic acid. The eluent A contained 2% ACN and 0.1% formic acid. The eluent B contained 80% ACN and 0.1% formic acid. The eluent A contained 300 nL / min for separating the eluent A with a molecular weight less than 3 kDa. The eluent B contained 5% B from 0 to 85 min, 5% B from 85 to 95 min, and 50% B from 95 to 125 min. The MS / MS data were used to evaluate the sequence of the eluted peptides. The spray voltage was 2.2 kV, the m / z scan range was 400 to 2000, the data acquisition time was 110 min, the capillary temperature was 200 °C, and the normalized collision energy was 35%. Finally, the MS / MS data were analyzed using Mascot (version 2.1.0, Matrix Sciences, London, UK).
[0064] Example 4
[0065] <Screening of antioxidant peptides using bioinformatics and verification of their antioxidant activity>
[0066] According to the results of mass spectrometry identification in Example 3, combined with bioinformatics, the PeptideRanker website ( http: / / distilldeep.ucd.ie / PeptideRanker / ) to predict the possibility that the antioxidant peptide is active, with the maximum value being 1. The larger the result, the greater the possibility that the peptide is active. https: / / web.expasy.org / protparam / ) predicts the molecular weight, hydrophilicity, hydrophobic amino acid content, and isoelectric point of the polypeptide. Preferably, the molecular weight, hydrophilicity, hydrophobic amino acid content, isoelectric point, and activity prediction results of the polypeptides identified in the hatched eggshell membrane hydrolysate are shown in Table 1 below, and polypeptides with an activity greater than 0.80 are preferably predicted.
[0067] Table 1. Molecular weight, hydrophilicity, hydrophobic amino acid content, and isoelectric point of peptides identified in hatching eggshell membrane hydrolysate
[0068]
[0069] Note: Negative GRAVY value represents hydrophilicity, the smaller the value, the more hydrophilic it is.
[0070] Preferably, the antioxidant peptides contained in the hatched eggshell membrane hydrolysate are obtained by solid phase synthesis, and the antioxidant indexes thereof are measured. The results are listed in Table 2 below.
[0071] Table 2 Antioxidant peptides contained in hatched eggshell membrane antioxidant peptide hydrolysate and their antioxidant activities
[0072]
[0073]
[0074] Note: Different letters represent significant differences (P<0.05), the same as Tables 4 and 5.
[0075] From Table 2 and Figure 2 The results show that the antioxidant peptides MDGWPR, LWNPR, and DGGLPPM show high ORAC values, and compared with the positive control GSH, the results of the above three antioxidant peptides are higher than those of the positive control GSH; the antioxidant peptides MDGWPR and LWNPR show high ABTS values, and compared with the positive control GSH, the results of the above two antioxidant peptides are higher than those of the positive control GSH; the antioxidant peptide MDGWPR shows a high DPPH value, which is slightly higher than the result of the positive control GSH. The DPPH values of the antioxidant peptides LWNPR and DGGLPPM are similar to those of the positive control GSH, and both show good antioxidant activity. From the results in the above table, it can be found that the antioxidant peptide MDGWPR simultaneously shows higher ORAC values, ABTS values, and DPPH values, and the results are better than those of the positive control GSH. The antioxidant peptide LWNPR also shows higher ORAC values and ABTS values, which shows that these peptides have excellent antioxidant activity.
[0076] The present invention provides the mass spectra of the above three antioxidant peptides:
[0077] in, Figure 3 is the mass spectrum of the hatched eggshell membrane antioxidant peptide LWNPR;
[0078] Figure 4 is the mass spectrum of the hatched eggshell membrane antioxidant peptide MDGWPR;
[0079] Figure 5 It is the mass spectrum of hatched eggshell membrane antioxidant peptide DGGLPPM.
[0080] The present invention provides an antioxidant peptide which can be used in food and medicine and shows high antioxidant activity, and a hatched eggshell membrane hydrolyzate containing the antioxidant peptide, which has the potential to be added to food and medicine as an antioxidant, and provides a theoretical basis for its ability to be used as an antioxidant.
[0081] Example 5
[0082] <Protective effect of antioxidant peptides on H2O2-induced SW1353 cells>
[0083] As a more preferred solution, the protective effect of the hatched eggshell membrane hydrolyzate containing the antioxidant peptide sequence of the present invention on the H2O2-induced SW1353 cell oxidative damage model can be determined according to the following method:
[0084] 1. Culture of SW1353 cells: SW1353 cells were cultured in DMEM high-glucose medium (containing 10% fetal bovine serum, 100 U / mL penicillin and 100 μg / mL streptomycin) in a 37°C, 5% CO2 saturated humidity incubator. Cells were cultured in monolayers and digested with 0.25% trypsin solution for subculture.
[0085] 2. Study on the effect of incubation eggshell membrane hydrolysate on SW1353 cell proliferation: SW1353 cells were cultured at 4×10 5 The cells were inoculated at a concentration of 100 cells / mL in a 6-well plate and cultured for 24 h. Eggshell membrane hydrolyzate (dissolved in cell culture medium and filtered through a 0.22 μm filter membrane to remove impurities and bacteria) was added at a final concentration of 0.75 mg / mL. The cell survival rate was measured after continuing to culture for 24 h.
[0086] 3. Establishment of SW1353 cell oxidative damage model (H2O2 model group): SW1353 cells were incubated at 4×10 5 The cells were seeded at a concentration of 100 μM / mL in a 6-well plate and cultured for 48 h. H2O2 solution (dissolved in DMEM) with a final concentration of 200 μM was added to each well and cultured for 1 h.
[0087] 4. Determination of SW1353 cell survival rate: SW1353 cells were cultured at 4×10 5 The cells were inoculated into a 6-well plate at a concentration of 100 μg / mL and cultured for 24 h. The eggshell membrane hydrolyzate (dissolved in the cell culture medium and filtered through a 0.22 μm filter to remove impurities and sterilize) was added at a final concentration of 0.75 mg / mL. The culture was continued for 24 h. H2O2 solution was added to each well at a final concentration of 200 μM and cultured for 1 h. The culture medium was removed and 100 μL CCK-8 solution (10%) was added to each well. The plate was placed in a 37°C, 5% CO2 saturated humidity incubator and cultured for 1 h. The absorbance value A of each well was measured by an ELISA reader. 450nm .
[0088] 5. The cell survival rate was calculated according to the following formula:
[0089]
[0090] Where A represents the A of the experimental group 450nm ; A0 represents A of the blank group 450nm ; A1 represents A in the normal group 450nm ;
[0091] The results are shown in Tables 3 and 4 below:
[0092] Table 3 Results of the effect of hatched eggshell membrane hydrolysate on SW1353 cell proliferation
[0093] Group Blank Group Peptide treatment group (0.75 mg / mL peptide pretreatment) SW1353 cell survival rate% 99.95±3.76 <![CDATA[299.57±5.64 *** ]]>
[0094] Note: “***” means P<0.001, the difference is extremely significant.
[0095] Table 4 Results of the protective effect of hatched eggshell membrane hydrolysate on H2O2-induced SW1353 cells
[0096]
[0097] It can be found from Table 3 that 0.75 mg / mL of hatching eggshell membrane hydrolysate pretreatment can promote the proliferation of SW1353 cells, and the cell survival rate is increased by 2.00 times compared with the blank group. It can be found from Table 4 that after 0.75 mg / mL of hatching eggshell membrane hydrolysate pretreatment, the survival rate of SW1353 cells is increased by 67.58% compared with the model group, indicating that the hatching eggshell membrane hydrolysate containing the antioxidant peptide sequence of the present invention can significantly improve the cell survival rate of the SW1353 cell oxidative damage model induced by H2O2.
[0098] Example 6
[0099] <Protective effect of antioxidant peptides on H2O2-induced RAW264.7 cells>
[0100] The hatched eggshell membrane hydrolyzate containing the antioxidant peptide sequence of the present invention can significantly improve the cell survival rate of the H2O2-induced RAW264.7 cell oxidative damage model. The specific operation method is the same as Example 5.
[0101] The results are shown in Table 5. Compared with the blank group, the cell survival rate of the H2O2 model group decreased significantly. After pretreatment with 0.75 mg / mL of hatched eggshell membrane hydrolyzate, the survival rate of RAW264.7 cells increased by 55.81% compared with the H2O2 model group.
[0102] Table 5 Results of the protective effect of incubated eggshell membrane hydrolysate on H2O2-induced RAW264.7 cells
[0103]
[0104] Example 7
[0105] <The effect of the antioxidant peptide LWNPR on the intracellular antioxidant pathway based on western blot>
[0106] RAW264.7 cells (5.1×10 5 Cells / well) were inoculated into 6-well plates and cultured for 24h. The preferred antioxidant peptide LWNPR (500 and 1000μM) was pretreated for 24h and 175μM H2O2 was treated for 1h, then RAW264.7 cells were collected and lysed with RIPA buffer containing PMSF and phosphatase inhibitors. After analyzing the total protein content (BCA kit), the protein (40μg) was separated by 12% SDS-PAGE gel and transferred to a PVDF membrane. Add 5mL of blocking solution for 1h, then remove the blocking solution, add the primary antibody diluted in the blocking solution, and slowly incubate at 4℃ overnight. Rinse with TBST 3 times, add the secondary antibody diluted in TBST, incubate at 24℃ for 1h, rinse with TBST 3 times, add ECL liquid to the washed PVDF membrane, let it react chemically for 1-2min, place it in a dark environment, and after developing and fixing, scan to obtain the results of western blot.
[0107] like Figure 6 As shown: compared with the blank group, the expression of Nrf2 and HO-1 proteins in the H2O2 group was reduced, while the expression of Keap1 was increased; after pretreatment with 500 and 1000 μM of the antioxidant peptide LWNPR, the expression of Nrf2 and HO-1 was increased, accompanied by a decrease in Keap1 expression, indicating that the hatching eggshell membrane antioxidant peptide provided by the present invention can activate the expression of proteins related to the Keap1-Nrf2 signaling pathway, thereby protecting inflammatory cells (RAW264.7) from damage by H2O2-induced oxidative stress.
[0108] Example 8
[0109] <Effects of the antioxidant peptide LWNPR on the intracellular antioxidant pathway based on molecular docking study>
[0110] Molecular docking was performed by the CDOCKER program of the Discovery Studio (DS) 2018 client software, with the hatched eggshell membrane antioxidant peptide of the present invention as a ligand and Keap1 (PDB ID: 2FLU) as a receptor. The docking results were expressed by the CDOCKER interaction energy (CIE) score, where a higher score indicates a tighter binding, and the specific values of the preferred hatched eggshell membrane antioxidant peptide are shown in Table 6.
[0111] Table 6 Molecular docking results of hatched eggshell membrane antioxidant peptides and Keap1
[0112] Peptide sequence –CIE DKLPGF 51.0025 ASNTDFFLR 76.8399 LWNPR 63.0303 MDGWPR 57.7207 DGGLPPM 56.0518
[0113] All the hatching eggshell membrane antioxidant peptides involved in the present invention can successfully dock with the active site of Keap1. Among them, LWNPR is a preferred hatching eggshell membrane antioxidant peptide, which is used to study the binding mechanism of hatching eggshell membrane antioxidant peptides and Keap1. The results are as follows Figure 7 As shown, LWNPR forms 6 conventional hydrogen bonds with Ser363, Arg380, Asn382, and Arg415 of Keap1, 1 carbon-hydrogen bond with Tyr572, and 3 π-alkyl bonds with His436, Tyr572, and Phe577. All of the above amino acid residues are key residues of the Keap1-Kelch domain at the Keapl-Nrf2 interaction binding site. This indicates that the hatched eggshell membrane antioxidant peptide can occupy the Nrf2 binding site in the Keap1-Kelch domain, thereby destroying the Keap1-Nrf2 interaction, inhibiting the ubiquitination degradation of Nrf2, and then activating the Keap1-Nrf2 signaling pathway, and has the potential to target the key antioxidant protein Keap1.
[0114] The antioxidant peptide of the present invention and the hatched eggshell membrane hydrolyzate containing the same can be used alone as an antioxidant, but when used in combination with one or more other substances having antioxidant activity or extracts containing these substances, the antioxidant activity can be synergistically enhanced.
[0115] The antioxidant peptide of the present invention and the hatched eggshell membrane hydrolyzate containing the antioxidant peptide can be used as medicines, preferably antioxidant foods, medicines, health products and beauty products.
[0116] In the production of antioxidant beverages, nutritional supplements and tablets that prevent food from self-oxidation or achieve physiological functions through oral intake, the antioxidant peptide of the present invention and the hatched eggshell membrane hydrolyzate containing the antioxidant peptide can be added thereto as an effective ingredient to exert the above-mentioned effects.
[0117] The above embodiments have provided a detailed introduction to the technical solutions provided by the present invention. Specific examples are used herein to illustrate the principles and implementation methods of the embodiments of the present invention. The description of the above embodiments is only applicable to help understand the principles of the embodiments of the present invention. At the same time, for those skilled in the art, according to the embodiments of the present invention, there may be changes in the specific implementation methods and application scopes. In summary, the content of this specification should not be understood as limiting the present invention.
Claims
1. An antioxidant peptide, characterized in that Its amino acid sequence is any of the following: LWNPR (Leu-Trp-Asn-Pro-Arg); MDGWPR(Met-Asp-Gly-Trp-Pro-Arg); DGGLPPM (Asp-Gly-Gly-Leu-Pro-Pro-Met).
2. A hatching eggshell membrane hydrolyzate, characterized in that It contains one or more of the following antioxidant peptides: An antioxidant peptide with an amino acid sequence of LWNPR (Leu-Trp-Asn-Pro-Arg); An antioxidant peptide with an amino acid sequence of MDGWPR (Met-Asp-Gly-Trp-Pro-Arg); An antioxidant peptide with the amino acid sequence of DGGLPPM (Asp-Gly-Gly-Leu-Pro-Pro-Met).
3. A food, characterized in that: It contains the antioxidant peptide according to claim 1 or the hatched eggshell membrane hydrolyzate according to claim 2.
4. An antioxidant drug, characterized in that: It contains the antioxidant peptide according to claim 1 or the hatched eggshell membrane hydrolyzate according to claim 2.
5. A health product, characterized in that: It contains the antioxidant peptide according to claim 1 or the hatched eggshell membrane hydrolyzate according to claim 2.
6. An antioxidant beauty product, characterized in that: It contains the antioxidant peptide according to claim 1 or the hatched eggshell membrane hydrolyzate according to claim 2.
7. The antioxidant beauty product according to claim 6, characterized in that: The addition amount of the hatching eggshell membrane hydrolyzate is 0.1-10wt%.
8. The antioxidant beauty product according to claim 6, characterized in that: The cosmetic products include facial masks, facial creams and lotions.
9. Use of the antioxidant peptide according to claim 1 or the hatched eggshell membrane hydrolyzate according to claim 2 in the manufacture of an antioxidant.
